Evidence-Based Treatment of Alzheimer's Disease.
10.5124/jkma.2009.52.4.417
- Author:
Dong Woo LEE
1
;
Yoon Seok HUH
;
Ki Woong KIM
Author Information
1. Department of Psychiatry, Inje University College of Medicine, Korea.
- Publication Type:Original Article
- Keywords:
Alzheimer's disease;
Pharmacotherapy;
Cholinesterase inhibitor;
Memantine;
Evidence
- MeSH:
Alzheimer Disease;
Cholinesterase Inhibitors;
Estrogens;
Evidence-Based Medicine;
Ginkgo biloba;
Memantine;
N-Methylaspartate;
Vitamins
- From:Journal of the Korean Medical Association
2009;52(4):417-425
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The pharmacological treatment of Alzheimer's disease is based on symptomatic therapy of cognitive decline and behavioral problems. Numerous therapies have been investigated for the treatment and prevention of Alzheimer's disease. We reviewed the current evidence-based medical research and guidelines of treatment for Alzheimer's disease. The use of cholinesterase inhibitors (ChEI) and N-methyl-D-aspartate (NMDA) inhibitors can bring about significant but modest therapeutic improvement. There is insufficient evidence to recommend vitamine E, estrogen, ginko biloba, or nonsteroidal anti-inflammatory drugs (NSAIDs) for the prevention or treatment of Alzheimer's disease. This article reviews the available data on current pharmacological treatments through evidence-based medicine.
